| Identification | Back Directory | [Name]
Rolapitant | [CAS]
552292-08-7 | [Synonyms]
SCH619734
Rolapitant
Rolapitant-d4
Rolapitant HCl
Rolapitant USP/EP/BP
Rolapitant(sch619734)
rolapitant,914462-92-3
(5S,8S)-8-({(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one
(5S,8S)-8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one
1,7-Diazaspiro[4.5]decan-2-one,8-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-,(5S,8S)-
(5S,8S)-8-[[[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethyl]oxy]methyl]-8-phenyl-1,7-diazaspiro[4.5]decan-2-one
(5S,8S)-8-(((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one hydrochloride. | [EINECS(EC#)]
812-147-5 | [Molecular Formula]
C25H26F6N2O2 | [MDL Number]
MFCD23105917 | [MOL File]
552292-08-7.mol | [Molecular Weight]
500.48 |
| Chemical Properties | Back Directory | [Boiling point ]
523.5±50.0 °C(Predicted) | [density ]
1.34±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMF: 25 mg/ml; DMF:PBS(pH7.2) (1:2): 0.33 mg/ml; DMSO: 16 mg/ml; Ethanol: 3 mg/ml | [form ]
Powder | [pka]
15.88±0.40(Predicted) |
| Hazard Information | Back Directory | [Definition]
ChEBI: An azaspiro compound that is 1,7-diazaspiro[4.5]decan-2-one carrying additional phenyl and 1-{[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl substituents at position 8. Used (in the form of the hydrochloride hydrate) for the prevention of delayed nausea and
vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. | [storage]
Store at -20°C |
|
|